Sars-Cov 2 and business continuity at Oxeltis Le 21 avril 202022 avril 2020 par oxeltis At Oxeltis, we are committed to continuing our medicinal chemistry research services during the Sars-Cov 2 outbreak, with respect to our staff’s safety and in accordance with the rules put in (...)